NorthAvenue LLC’s Corteva CTVA Stock Holding History

NorthAvenue LLC’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4	Closed	-$269	–	295
2025 Q4	$269	Buy	+4	New	+$259	﹤0.01%	316

Other funds holding CTVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

NorthAvenue LLC's CTVA Position: Q1 2026 in Review

NorthAvenue LLC sold out of Corteva (CTVA) in Q1 2026, closing a stake of 4 shares — an estimated $269 sold.

NorthAvenue LLC first reported a position in CTVA in Q4 2025 and held it in 1 quarter. The position peaked at $269 in Q4 2025. 1,478 funds tracked by Wall St. Rank hold CTVA as of Q1 2026.

NorthAvenue LLC reported no remaining Corteva position as of Q1 2026 after selling out during the quarter.
NorthAvenue LLC sold 4 Corteva shares in Q1 2026, an estimated $269.
NorthAvenue LLC first reported a position in Corteva in Q4 2025 and held it in 1 quarter.
NorthAvenue LLC's Corteva position peaked at $269 in Q4 2025.
1,478 funds tracked by Wall St. Rank held Corteva as of Q1 2026.

Based on NorthAvenue LLC's 13F filing for Q1 2026, filed 15 Apr 2026.